IRWD icon

Ironwood Pharmaceuticals

226 hedge funds and large institutions have $1.12B invested in Ironwood Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 79 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

26% less capital invested

Capital invested by funds: $1.5B → $1.12B (-$383M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

60% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 52

Holders
226
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$73.6M
Puts
$186K
Net Calls
Net Calls Change

Top Buyers

1 +$17M
2 +$15.4M
3 +$14.4M
4
Pacer Advisors
Pacer Advisors
Pennsylvania
+$12M
5
Renaissance Technologies
Renaissance Technologies
New York
+$10.4M

Top Sellers

1 -$33.1M
2 -$9.79M
3 -$9.06M
4
UBS Group
UBS Group
Switzerland
-$8.4M
5
SSA
Schonfeld Strategic Advisors
New York
-$6.83M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$318K
127
$313K
128
$312K
129
$296K
130
$292K
131
$292K
132
$289K
133
$289K
134
$282K
135
$278K
136
$273K
137
$272K
138
$257K
139
$256K
140
$251K
141
$244K
142
$241K
143
$240K
144
$235K
145
$233K
146
$230K
147
$226K
148
$221K
149
$215K
150
$215K